Efficacy of lapatinib combined with capecitabine in patients with HER2-positive metastatic breast cancer in a real-world study

por Gui, Xinyu, Li, Huiping, Yan, Ying, Zhang, Ruyan
Publicado 2020

Efficacy and Safety of Fulvestrant 500mg in Hormone-receptor Positive Human Epidermal Receptor 2 Negative Advanced Breast Cancer: A Real-world Study in China

por Lei, Wen, Li, Huiping, Song, Guohong, Zhang, Ruyan, Ran, Ran, Yan, Ying, Di, Lijun, Jiang, Hanfang
Publicado 2020

Risk factors for cardiac rupture after acute ST-segment elevation myocardial infarction during the percutaneous coronary intervention era: a retrospective case-control study

por Xu, Zesheng, Li, Yingkai, Zhang, Ruyan, Liu, Yongqing, Liu, Hua, Yu, Jiancai, Zhou, Xianbo, Du, Yihui, Cong, Hongliang
Publicado 2022

Free Vascularized Fibula Salvage of Failed CPH in Pediatric Sarcoma Patients

por Pires, Giovanna, Moss, Whitney D., Luo, Jessica, Zhang, Ruyan, Jones, Kevin B, Kwok, Alvin C, Agarwal, Jayant P
Publicado 2022

Clinicopathological features and prognosis of patients with pregnancy‐associated breast cancer: A matched case control study

por Zhang, Ruyan, Liu, Xiaoran, Huang, Wenfa, Shao, Bin, Yan, Ying, Liang, Xu, Ran, Ran, Song, Guohong, Di, Lijun, Jiang, Hanfang, Li, Huiping
Publicado 2021

Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world setting

por Zhang, Ruyan, Chen, Yifei, Liu, Xiaoran, Gui, Xinyu, Zhu, Anjie, Jiang, Hanfang, Shao, Bin, Liang, Xu, Yan, Ying, Zhang, Jiayang, Song, Guohong, Li, Huiping
Publicado 2023

Germline Mutational Landscape in Chinese Patients With Advanced Breast Cancer

por Zhang, Jiayang, Wang, Nan, Zheng, Tiantian, Lu, Tan, Zhang, Ruyan, Ran, Ran, Li, Kun, Huang, Yong, Xie, Feng, Zhang, Yue, Jia, Shidong, Yu, Jianjun, Li, Huiping
Publicado 2022

Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer

por Shao, Bin, Liu, Xiaoran, Li, Huiping, Song, Guohong, Di, Lijun, Jiang, Hanfang, Yan, Ying, Zhang, Ruyan, Ran, Ran, Zhang, Jiayang, Liu, Yaxin, Wang, Huan, Wang, Jing
Publicado 2022

The prognostic value of neutrophil-to-lymphocyte ratio in de novo stage IV breast cancer: a retrospective cohort study

por Shao, Bin, Li, Huiping, Liu, Xiaoran, Song, Guohong, Jiang, Hanfang, Yan, Ying, Zhang, Ruyan, Ran, Ran, Zhang, Jiayang, Liu, Yaxin, Wang, Huan, Wang, Jing, Di, Lijun
Publicado 2023

Pegylated liposomal doxorubicin (Duomeisu(®)) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, p...

por Jiang, Hanfang, Li, Huiping, Song, Guohong, Di, Lijun, Shao, Bin, Yan, Ying, Liu, Xiaoran, Chen, Yifei, Zhang, Ruyan, Ran, Ran, Liu, Yaxin, Gui, Xinyu, Wang, Nan, Wang, Huan
Publicado 2023

Bilateral breast cancer in China: A 10‐year single‐center retrospective study (2006–2016)

por Jiang, Hanfang, Zhang, Ruyan, Liu, Xiaoran, Ran, Ran, Zhang, Jiayang, Liu, Yaxin, Gui, Xinyu, Chen, Yifei, Li, Kun, Shao, Bin, Yan, Ying, Liang, Xu, Song, Guohong, Di, Lijun, Li, Huiping
Publicado 2021

Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer

por Li, Huiping, Song, Guohong, Zhou, Qiaoxia, Ran, Ran, Jiang, Hanfang, Zhang, Ruyan, Liu, Yaxin, Zhang, Jiayang, Meng, Luping, Ma, Liandong, Sun, Ye, Wang, Meiyu, Zhou, Qingqing, Yan, Honghua, Zhou, Qianxiang, Dong, Xunwei, Tong, Youzhi
Publicado 2021

A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation an...

por Liu, Yaxin, Wang, Wei, Yin, Rutie, Zhang, Youzhong, Zhang, Yu, Zhang, Keqiang, Pan, Hongming, Wang, Ke, Lou, Ge, Li, Guiling, Zhang, Ruyan, Li, Kun, Rao, Jing, Zhang, Ben, Wang, Yuting, Wang, Quanren, Gao, Yunong, Li, Huiping
Publicado 2023